MedPath

Glycopyrrolate

glycopyrrolate

Approved
Approval ID

d93a9b2b-708d-4db5-8aae-45fd3a7ca65c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 4, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

glycopyrrolate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72162-1477
Application NumberANDA040653
Product Classification
M
Marketing Category
C73584
G
Generic Name
glycopyrrolate
Product Specifications
Route of AdministrationORAL
Effective DateDecember 13, 2018
FDA Product Classification

INGREDIENTS (6)

GLYCOPYRROLATEActive
Quantity: 1 mg in 1 1
Code: V92SO9WP2I
Classification: ACTIB
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Glycopyrrolate - FDA Drug Approval Details